Mupirocin Calcium

HCID 5282317CAS 115074-43-6

기본 정보

표준 SMILES: C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.C/C(=C\C(=O)OCCCCCCCCC(=O)[O-])C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O.O.O.[Ca+2]
InChIKey: DDHVILIIHBIMQU-YJGQQKNPSA-L
분자식: C52H90CaO20
평균 분자량: 1,075.3 g/mol

개요

Mupirocin calcium hydrate is a hydrate that is the dihydrate form of mupirocin calcium. It is an antibacterial drug used for the treatment of skin infections such as impetigo caused by Staphylococcus aureus and meticillin-resistant Staphylococcus aureus (MRSA). It has a role as an antiinfective agent, an antibacterial drug and a protein synthesis inhibitor. It contains a mupirocin calcium (anhydrous).

이름 및 식별자

우선 이름: Mupirocin Calcium
IUPAC: calcium;bis(9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate);dihydrate

이름 및 동의어

Mupirocin calciumMupirocin calcium dihydratemupirocin calcium hydrateBRL 4910FBRL-4910FRG38I2P540CHEBI:34858DTXSID90883142PirnuoRefChem:55673DTXCID301510752Monocalcium bis(9-((2E)-4-((2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxy-3,4,5,6-tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyloxy)nonanoate) dihydrate

이름 더 보기

115074-43-6BactrobanCalcium mupirocin dihydratemupirocin calcium saltBactroban (TN)Calcium pseudomonateCalcium 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate dihydratecalcium;9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate;dihydrate

데이터베이스 식별자

CAS: 115074-43-6
PubChem CID: 5282317
ChEMBL: CHEMBL3989715
ChEBI: CHEBI:34858
UNII: RG38I2P540
EC Number: 658-053-6

물성

구조 계산 물성

극성 표면적: 300 Å²
수소 결합 공여자 수: 8
수소 결합 수용자 수: 20
회전 가능 결합 수: 32
무거운 원자 수: 73
형식 전하: 0
복잡도: 689

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

안전 및 규제

GHS 분류

GHS Classification · 4건

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

MUPIROCIN CALCIUM

RNA Synthetase Inhibitors [MoA]; RNA Synthetase Inhibitor Antibacterial [EPC]

MeSH Pharmacological Classification · 2건

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.

Substances that inhibit the growth or reproduction of BACTERIA.